Multi-Society Expert Panel Consensus Guidance Regarding Clinical Assessment and Clinical Trial Endpoints in Adults With Alpha-1 Antitrypsin Deficiency–Associated Liver Disease Post author:GIBoardReview.com Post published:May 27, 2026 Post category:Society Guidelines You Might Also Like AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders August 1, 2020 AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review August 12, 2025 AGA Clinical Practice Update on Management of Medically Refractory Gastroparesis: Expert Review February 24, 2022
AGA Clinical Practice Guidelines on the Role of Probiotics in the Management of Gastrointestinal Disorders August 1, 2020
AGA Clinical Practice Update on GI Manifestations and Autonomic or Immune Dysfunction in Hypermobile Ehlers-Danlos Syndrome: Expert Review August 12, 2025
AGA Clinical Practice Update on Management of Medically Refractory Gastroparesis: Expert Review February 24, 2022